These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19584439)

  • 1. Astrocyte function is modified by Alzheimer's disease-like pathology in aged mice.
    Peters O; Schipke CG; Philipps A; Haas B; Pannasch U; Wang LP; Benedetti B; Kingston AE; Kettenmann H
    J Alzheimers Dis; 2009; 18(1):177-89. PubMed ID: 19584439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
    Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D
    Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
    Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
    Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.
    Damjanac M; Rioux Bilan A; Barrier L; Pontcharraud R; Anne C; Hugon J; Page G
    Brain Res; 2007 Jan; 1128(1):40-9. PubMed ID: 17125750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
    Minkeviciene R; Ihalainen J; Malm T; Matilainen O; Keksa-Goldsteine V; Goldsteins G; Iivonen H; Leguit N; Glennon J; Koistinaho J; Banerjee P; Tanila H
    J Neurochem; 2008 May; 105(3):584-94. PubMed ID: 18042177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein-I and -III expression in animal models of Alzheimer disease.
    Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
    Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer's disease.
    Yang J; Lunde LK; Nuntagij P; Oguchi T; Camassa LM; Nilsson LN; Lannfelt L; Xu Y; Amiry-Moghaddam M; Ottersen OP; Torp R
    J Alzheimers Dis; 2011; 27(4):711-22. PubMed ID: 21891870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
    Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
    van Groen T; Kadish I
    Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice.
    Rodrigo J; Fernández-Vizarra P; Castro-Blanco S; Bentura ML; Nieto M; Gómez-Isla T; Martínez-Murillo R; MartInez A; Serrano J; Fernández AP
    Neuroscience; 2004; 128(1):73-89. PubMed ID: 15450355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
    Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
    Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
    Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques.
    Steinhoff T; Moritz E; Wollmer MA; Mohajeri MH; Kins S; Nitsch RM
    Neurobiol Dis; 2001 Aug; 8(4):647-54. PubMed ID: 11493029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons.
    Gärtner U; Brückner MK; Krug S; Schmetsdorf S; Staufenbiel M; Arendt T
    Acta Neuropathol; 2003 Dec; 106(6):535-44. PubMed ID: 12923647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
    Schenk D; Barbour R; Dunn W; Gordon G; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; Kholodenko D; Lee M; Liao Z; Lieberburg I; Motter R; Mutter L; Soriano F; Shopp G; Vasquez N; Vandevert C; Walker S; Wogulis M; Yednock T; Games D; Seubert P
    Nature; 1999 Jul; 400(6740):173-7. PubMed ID: 10408445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.